IRIS
MARZIONI, Marco
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 10.826
EU - Europa 4.773
AS - Asia 4.164
SA - Sud America 1.103
AF - Africa 217
Continente sconosciuto - Info sul continente non disponibili 9
OC - Oceania 7
Totale 21.099
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 10.664
SG - Singapore 1.306
VN - Vietnam 943
BR - Brasile 851
RU - Federazione Russa 841
IT - Italia 750
CN - Cina 675
UA - Ucraina 669
IE - Irlanda 444
DE - Germania 412
SE - Svezia 402
HK - Hong Kong 365
FR - Francia 322
GB - Regno Unito 226
DK - Danimarca 223
FI - Finlandia 217
TR - Turchia 203
BD - Bangladesh 134
KR - Corea 117
IN - India 114
CA - Canada 84
AR - Argentina 79
CI - Costa d'Avorio 59
MA - Marocco 59
NL - Olanda 54
ES - Italia 51
PL - Polonia 50
EC - Ecuador 46
IQ - Iraq 46
MX - Messico 46
JP - Giappone 45
ID - Indonesia 43
ZA - Sudafrica 42
CO - Colombia 38
PY - Paraguay 25
BE - Belgio 24
VE - Venezuela 24
AT - Austria 21
PK - Pakistan 20
UZ - Uzbekistan 20
PH - Filippine 19
CL - Cile 17
TN - Tunisia 16
SA - Arabia Saudita 13
JO - Giordania 12
TH - Thailandia 12
LT - Lituania 10
PE - Perù 10
RO - Romania 10
UY - Uruguay 10
AZ - Azerbaigian 9
DZ - Algeria 8
EG - Egitto 8
IL - Israele 8
RS - Serbia 8
AE - Emirati Arabi Uniti 7
ET - Etiopia 6
EU - Europa 6
KE - Kenya 6
LB - Libano 6
TW - Taiwan 6
HN - Honduras 5
IR - Iran 5
MY - Malesia 5
AO - Angola 4
BY - Bielorussia 4
CH - Svizzera 4
CR - Costa Rica 4
PS - Palestinian Territory 4
AL - Albania 3
AU - Australia 3
BA - Bosnia-Erzegovina 3
BH - Bahrain 3
CZ - Repubblica Ceca 3
DO - Repubblica Dominicana 3
GT - Guatemala 3
HU - Ungheria 3
JM - Giamaica 3
KZ - Kazakistan 3
LV - Lettonia 3
MN - Mongolia 3
NI - Nicaragua 3
NP - Nepal 3
OM - Oman 3
PR - Porto Rico 3
SN - Senegal 3
BG - Bulgaria 2
BO - Bolivia 2
CY - Cipro 2
EE - Estonia 2
GA - Gabon 2
GE - Georgia 2
GR - Grecia 2
HR - Croazia 2
KG - Kirghizistan 2
LY - Libia 2
MD - Moldavia 2
NZ - Nuova Zelanda 2
PT - Portogallo 2
SK - Slovacchia (Repubblica Slovacca) 2
Totale 21.075
Salva come PNG Salva come JPEG
Città #
Ashburn 1.624
Chandler 764
Singapore 750
Jacksonville 698
Dallas 664
Fairfield 592
San Jose 453
Dublin 443
Des Moines 430
Boardman 391
Hong Kong 347
Council Bluffs 288
Ho Chi Minh City 287
New York 282
Woodbridge 277
Wilmington 276
Houston 269
The Dalles 231
Hanoi 230
Seattle 229
Los Angeles 210
Cambridge 207
Centro 202
Lauterbourg 170
Lawrence 161
Princeton 160
San Mateo 148
Moscow 129
Ann Arbor 124
Beijing 123
San Diego 84
Hefei 83
Munich 77
Buffalo 70
Chicago 70
Orem 70
São Paulo 69
Milan 67
Helsinki 66
Abidjan 59
Washington 59
London 56
Santa Clara 54
Da Nang 51
Haiphong 46
Turku 41
Warsaw 40
Guangzhou 36
Brooklyn 35
Denver 35
Rio de Janeiro 34
Montreal 33
Shanghai 33
Turin 32
Ancona 31
Tokyo 31
Nuremberg 28
Chennai 26
Johannesburg 26
Wuhan 23
Atlanta 22
Baghdad 22
Rome 22
Salt Lake City 22
Columbus 19
Hải Dương 19
Miano 19
Pune 19
Toronto 19
Brussels 18
Frankfurt am Main 18
Guayaquil 18
San Francisco 18
Stockholm 18
Ankara 17
Norwalk 17
Phoenix 17
Poplar 17
Manchester 16
Marche 16
Tashkent 16
Mexico City 15
Boston 14
Brasília 14
City of London 14
Elk Grove Village 14
Porto Alegre 14
Thái Nguyên 14
Wuxi 14
Salvador 13
Belo Horizonte 12
Bắc Ninh 12
Can Tho 12
Jiaxing 12
Salamanca 12
Tampa 12
Curitiba 11
Dhaka 11
Quito 11
Quận Ba 11
Totale 13.255
Salva come PNG Salva come JPEG
Nome #
EASL Clinical Practice Guidelines on the management of extrahepatic cholangiocarcinoma 237
Use of nailfold capillaroscopy for the early diagnosis of systemic sclerosis in patients with primary biliary cholangitis 216
Prevalence and clinical outcome of hepatic haemangioma with specific reference to the risk of rupture: a large retrospective cross-sectional study. 206
Ageing-related expression of Twinfilin-1 regulates cholangiocyte biological response to injury 194
A model of insulin resistance and nonalcoholic steatohepatitis in rats: role of peroxisome proliferator-activated receptor-alpha and n-3 polyunsaturated fatty acid treatment on liver injury 187
HDL cholesterol protects from liver injury in mice with intestinal specific LXRα activation 184
Farnesoid X Receptor, Bile Acid Metabolism, and Gut Microbiota 171
Bile acid feeding increased proliferative activity and apical bile acid transporter expression in both small and large rat cholangiocytes 170
An oestrogen receptor β-selective agonist exerts anti-neoplastic effects in experimental intrahepatic cholangiocarcinoma. 169
Activation of the developmental pathway neurogenin-3/microRNA-7a regulates cholangiocyte proliferation in response to injury. 169
Nlrp3 Activation Induces Il-18 Synthesis and Affects the Epithelial Barrier Function in Reactive Cholangiocytes 169
H3 histamine receptor agonist inhibits biliary growth of BDL rats by downregulation of the cAMP-dependent PKA/ERK1/2/ELK-1 pathway. 168
Aging and the Biological Response to Liver Injury 168
Lack of NLRP3-inflammasome leads to gut-liver axis derangement, gut dysbiosis and a worsened phenotype in a mouse model of NAFLD. 165
Exendin-4 restores ppar-alpha and ppar-gamma activity in nash and reduces insulin resistance, pro-inflammatory mediators and total fatty acid content 164
Endogenous opioids modulate the growth of the biliary tree in the course of cholestasis 163
HCC development is associated to peripheral insulin resistance in a mouse model of NASH 155
Endoplasmic Reticulum stress induces hepatic stellate cell apoptosis and contributes to fibrosis resolution 154
Shear wave elastography and transient elastography in HCV patients after direct-acting antivirals 154
Aging-Related Molecular Pathways in Chronic Cholestatic Conditions 152
Hepatic fibrogenesis in response to chronic liver injury: novel insights on the role of cell-to-cell interaction and transition. 151
Long-term albumin administration in decompensated cirrhosis (ANSWER): an open-label randomised trial 150
Proliferating cholangiocytes: a neuroendocrine compartment in the diseased liver. 149
Descriptive epidemiology of cholangiocarcinoma in Italy. 149
Leptin enhances cholangiocarcinoma cell growth. 149
Gut-Liver Axis and Inflammasome Activation in Cholangiocyte Pathophysiology 147
Clinical implications of novel aspects of biliary pathophysiology. 146
Expert consensus document: Cholangiocarcinoma: current knowledge and future perspectives consensus statement from the European Network for the Study of Cholangiocarcinoma (ENS-CCA) 146
Research Strands in Dermatology and Gastroenterology Units of Department of Clinical and Molecular Sciences in Polytechnic Marche University 145
Functional and Structural Features of Cholangiocytes in Health and Disease 145
Hepatitis E in a region of Italy: An emerging autochthonous infection? 144
SOX17 regulates cholangiocyte differentiation and acts as a tumor suppressor in cholangiocarcinoma 143
Exendin-4, a Glucagon-Like Peptide 1 receptor agonist, protects cholangiocytes from apoptosis 142
Bile acid depletion and repletion regulate cholangiocyte proliferation and secretion in bile duct ligated rats through a phosphatidylinositol 3-kinase-dependent pathway. 141
Administration of r-VEGF-A prevents hepatic artery ligation induced bile duct damage in bile duct ligated rats. 141
Cholangiocarcinoma development: the resurgence of bile acids 141
cAMP stimulates the secretory and proliferative capacity of the rat intrahepatic biliary epithelium through changes in the PKA/Src/MEK/ERK1/2 pathway 139
Exendin-4, a glucagon-like protein-1 receptor agonist, reduces proinflammatory conditions, and increases lipid oxidation and insulin sensitivity in hepatocytes from nonalcoholic steatohepatitis rats 138
Bullous pemphigoid of Lever and celiac disease: a coincidental occurrence or an unusual association? 138
Current targets for Primary Sclerosing cholangitis 138
Dysbiosis contributes to fibrogenesis in the course of chronic liver injury in mice 137
CAMP STIMULATES THE SECRETORY AND PROLIFERATIVE CAPACITY OF THE RAT BILIARY EPITHELIUM THROUGH CHANGES IN THE PKA/SRC/MEK/ERK1/2 PATHWAY 136
Safety and efficacy of ombitasvir/paritaprevir/ritonavir/dasabuvir plus ribavirin in patients over 65 years with HCV genotype 1 cirrhosis 136
Cholangiocarcinoma 2020: the next horizon in mechanisms and management 136
Increased local dopamine secretion has growth promoting effects in cholangiocarcinoma. 135
On-treatment serum albumin level can guide long-term treatment in patients with cirrhosis and uncomplicated ascites 134
Vascular endothelial growth factor stimulates rat cholangiocyte proliferation via an autocrine mechanism. 133
PDX-1 mRNA expression in endoscopic ultrasound-guided fine needle cytoaspirate: Perspectives in the diagnosis of pancreatic cancer 133
Inflammation and the Gut-Liver Axis in the Pathophysiology of Cholangiopathies 133
Patient Age, Sex, and Inflammatory Bowel Disease Phenotype Associate With Course of Primary Sclerosing Cholangitis 132
Current and novel therapeutic opportunities for systemic therapy in biliary cancer 132
Pancreatic Duodenal Homeobox-1 de novo expression drives cholangiocyte neuroendocrine-like transdifferentiation. 131
Ca2+-dependent cytoprotective effects of ursodeoxycholic and tauroursodeoxycholic Acid on the biliary epithelium in a rat model of cholestasis and loss of bile ducts 131
Gastrin reverses established cholangiocyte proliferation and enhanced secretin-stimulated ductal secretion of BDL rats by activation of apoptosis through increased expression of Ca2+- dependent PKC isoforms. 130
Gastrointestinal Complications after Allogeneic Hematopoietic Stem Cell Transplant: A Multidisciplinary Approach with Early Endoscopic Evaluation 130
Angiogenic factors in chronic liver diseases: the effects on hepatic progenitor cells 129
Role of inflammation and proinflammatory cytokines in cholangiocyte pathophysiology 129
Selective inhibition of ion transport mechanisms regulating intracellular pH reduces proliferation and induces apoptosis in cholangiocarcinoma cells. 127
Semaphorin 7A contributes to TGF-β-mediated liver fibrogenesis 127
Targeting UBC9-mediated protein hyper-SUMOylation in cystic cholangiocytes halts polycystic liver disease in experimental models 127
Cancer-Associated Fibroblasts in Cholangiocarcinoma: Current Knowledge and Possible Implications for Therapy 126
Effect of pirfenidone on rat hepatic stellate cell proliferation and collagen production. 124
Cholangiocarcinoma in Italy: A national survey on clinical characteristics, diagnostic modalities and treatment. Results from the "Cholangiocarcinoma" committee of the Italian Association for the Study of Liver disease. 123
Locally acquired hepatitis E virus in Marche Italy: Clinical/laboratory features and outcome 122
Serum and biliary insulin-like growth factor I and vascular endothelial growth factor in determining the cause of obstructive cholestasis 121
Autocrine/paracrine regulation of the growth of the biliary tree by the neuroendocrine hormone serotonin 121
Follow-up magnetic resonance imaging/3D-magnetic resonance cholangiopancreatography in patients with primary sclerosing cholangitis: challenging for experts to interpret 121
Involvement of autophagy in ageing and chronic cholestatic diseases 121
Ombitasvir, paritaprevir, and ritonavir, with or without dasabuvir, plus ribavirin for patients with hepatitis C virus genotype 1 or 4 infection with cirrhosis (ABACUS): a prospective observational study 120
Bile Acids in Polycystic Liver Diseases: Triggers of Disease Progression and Potential Solution for Treatment 120
Taurohyodeoxycholate- and tauroursodeoxycholate-induced hypercholeresis is augmented in bile duct ligated rats 119
Secretin stimulates biliary cell proliferation by regulating expression of microRNA 125b and microRNA let7a in mice 118
Cariporide a selective Na+ /H+ exchange inhibitor, reduces PDGF-induced proliferation and oxidative stress product formation in rat hepatic stellate cells (HSC). 118
Pathway-based analysis of primary biliary cirrhosis genome-wide association studies. 118
Mouse models of liver fibrosis mimic human liver fibrosis of different etiologies 117
International genome-wide meta-analysis identifies new primary biliary cirrhosis risk loci and targetable pathogenic pathways 117
Serum micrornas as novel biomarkers for primary sclerosing cholangitis and cholangiocarcinoma 117
Role of cholangiocytes in primary biliary cirrhosis 116
The Impact of Radiofrequency Ablation on Survival Outcomes and Stent Patency in Patients with Unresectable Cholangiocarcinoma: A Systematic Review and Meta-Analysis of Randomized Controlled Trials 115
Taurocholic acid feeding prevents tumor necrosis factor-alpha-induced damage of cholangiocytes by a PI3K-mediated pathway. 115
An international genome-wide meta-analysis of primary biliary cholangitis: Novel risk loci and candidate drugs 115
Risk Stratification in Primary Biliary Cholangitis 115
Selective Na+/H+ inhibition by cariporide reduces liver fibrosis in the rat 114
Autocrine Regulation of Biliary Pathology by Activated Cholangiocytes. 114
Glucagon-like Peptide-1 and its receptor agonist exendin-4 modulate cholangiocyte adaptive response to cholestasis 114
Hemostatic balance in patients with liver cirrhosis: Report of a consensus conference 114
Accuracy of Transient Elastography in Assessing Fibrosis at Diagnosis in Naïve Patients With Primary Biliary Cholangitis: A Dual Cut-Off Approach 114
Role of apoptosis in development of primary biliary cirrhosis 113
Effects of Vedolizumab in Patients with Primary Sclerosing Cholangitis and Inflammatory Bowel Diseases 113
Measurement of Gamma Glutamyl Transferase to Determine Risk of Liver Transplantation or Death in Patients With Primary Biliary Cholangitis 113
Genetic association analysis identifies variants associated with disease progression in primary sclerosing cholangitis 112
Selective Na+/H+ exchange inhibition by cariporide reduces liver fibrosis in the rat. 111
Serum extracellular vesicles contain protein biomarkers for primary sclerosing cholangitis and cholangiocarcinoma 111
Patients with Cholangiocarcinoma Present Specific RNA Profiles in Serum and Urine Extracellular Vesicles Mirroring the Tumor Expression: Novel Liquid Biopsy Biomarkers for Disease Diagnosis 110
Cholangiocyte injury and ductopenic syndromes. 109
Hepatic, gastric and bone marrow AL amyloidosis that began with Budd-Chiari syndrome: a case report 108
Functional heterogeneity of the intrahepatic biliary tree 108
The significance of genetics for cholangiocarcinoma development 108
EASL Clinical Practice Guidelines: The diagnosis and management of patients with primary biliary cholangitis 108
Epidemiology of primary biliary cholangitis in Italy: Evidence from a real-world database 108
Totale 13.656
Salva come PNG Salva come JPEG
Categoria #
all - tutte 104.656
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 104.656
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.351 71 341 19 36 14 68 79 83 67 98 219 256
2022/20232.495 212 202 140 188 154 616 4 160 600 13 159 47
2023/20241.519 246 33 118 302 241 326 16 29 11 27 10 160
2024/20252.771 317 277 103 45 82 115 159 96 702 206 282 387
2025/20268.578 501 450 695 1.099 840 573 1.451 828 723 740 287 391
2026/2027388 388 0 0 0 0 0 0 0 0 0 0 0
Totale 21.554